AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG RatingBSE filing · raw filing ↗
25 Aug 2026
⚑ Filing
Action(s) taken or orders passedNSE filing · raw filing ↗
25 Aug 2026
⚑ Filing
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE filing · raw filing ↗
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG RatingBSE filing · raw filing ↗
21 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
21 Aug 2026
⚑ Filing
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE filing · raw filing ↗
15 Aug 2026
⚑ Filing
Analysts/Institutional Investor Meet/Con. Call UpdatesNSE filing · raw filing ↗
15 Aug 2026
⚑ Filing
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
